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Proteome-wide analysis of phospho-regulated PDZ
domain interactions
Gustav N Sundell1, Roland Arnold2,*, Muhammad Ali1 , Piangfan Naksukpaiboon2, Julien Orts3,
Peter Güntert3,4, Celestine N Chi5,** & Ylva Ivarsson1,***
Abstract
A key function of reversible protein phosphorylation is to regulate
protein–protein interactions, many of which involve short linear
motifs (3–12 amino acids). Motif-based interactions are difficult to
capture because of their often low-to-moderate affinities. Here,
we describe phosphomimetic proteomic peptide-phage display,
a powerful method for simultaneously finding motif-based
interaction and pinpointing phosphorylation switches. We compu-
tationally designed an oligonucleotide library encoding human
C-terminal peptides containing known or predicted Ser/Thr phos-
phosites and phosphomimetic variants thereof. We incorporated
these oligonucleotides into a phage library and screened the PDZ
(PSD-95/Dlg/ZO-1) domains of Scribble and DLG1 for interactions
potentially enabled or disabled by ligand phosphorylation. We
identified known and novel binders and characterized selected
interactions through microscale thermophoresis, isothermal titra-
tion calorimetry, and NMR. We uncover site-specific phospho-regu-
lation of PDZ domain interactions, provide a structural framework
for how PDZ domains accomplish phosphopeptide binding, and
discuss ligand phosphorylation as a switching mechanism of PDZ
domain interactions. The approach is readily scalable and can be
used to explore the potential phospho-regulation of motif-based
interactions on a large scale.
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Introduction
Reversible protein phosphorylation is crucial for regulation of cellu-
lar processes and primarily occurs on Ser, Thr, and Tyr residues in
eukaryotes (Seet et al, 2006). Phosphorylation may have different
functional effects on the target protein, such as inducing conforma-
tional changes, altering cellular localization, or enabling or disabling
interaction sites. Hundreds of thousands of such phosphosites have
been identified in different cell lines and under different conditions
(Olsen et al, 2006; Hornbeck et al, 2015). An unresolved question is
which of these phosphosites are of functional relevance and not
background noise caused by the off-target activity of kinases
revealed by the high sensitivity in the mass spectrometry analysis.
So far, only a minor fraction of identified phosphosites has been
linked to functional effects, and only 35% of phosphosites are
evolutionarily conserved, which would support that they play non-
redundant functional roles (Landry et al, 2009). Sifting functional
from non-functional phosphosites by experimental approaches is
thus of fundamental importance in order to better understand the
function of the phosphoproteome.
Phosphosites are often located in the intrinsically disordered
regions of proteins, which in eukaryotes are estimated to cover 30–
40% of the populated protein sequence space (Ward et al, 2004).
These regions are enriched in short linear motifs (SLiMs, 3–12
amino acids) that are recognized by modular domains (Van Roey
et al, 2014). Discrete phosphorylation events may regulate and tune
the strength of interactions. Phosphopeptide binding domains, such
as the 14-3-3 proteins, serve as readers of this phosphorylation code
(Yaffe et al, 1997; Reinhardt & Yaffe, 2013). Deciphering the phos-
phorylation code by linking the reader domains to their preferred
binding phosphosites is a major challenge. Adding to the complex-
ity, phosphorylation of a SLiM may have a switch-like effect,
making the interaction stronger (enabling) with a given domain,
while weakening interactions (disabling) with other domains (Van
Roey et al, 2013), in other worlds regulating interactions. Such a
switch-like mechanism was recently found to regulate interactions
1 Department of Chemistry – BMC, Uppsala University, Uppsala, Sweden
2 Institute of Cancer and Genomic Sciences, College of Medical and Dental Sciences, University of Birmingham, Edgbaston, Birmingham, UK
3 Laboratory of Physical Chemistry, ETH Zürich, Zürich, Switzerland
4 Institute of Biophysical Chemistry, Goethe University, Frankfurt am Main, Germany
5 Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden
*Corresponding author. Tel: +44 7936624996; E-mail: r.arnold.2@bham.ac.uk
**Corresponding author. Tel: +46 18 471 4557; E-mail: chi.celestine@imbim.uu.se
***Corresponding author. Tel: +46 18 471 40 38; E-mail: ylva.ivarsson@kemi.uu.se
ª 2018 The Authors. Published under the terms of the CC BY 4.0 license Molecular Systems Biology 14: e8129 | 2018 1 of 22
Published online: August 20, 2018 
of the C-terminal region of PRTM5 with 14-3-3 proteins and PDZ
(PSD-95/Discs-large/ZO-1) domains. Phosphorylation of the C-term-
inal tail of PRTM5 enables 14-3-3 interactions, while disabling PDZ
domain interactions (Espejo et al, 2017). Although less common,
phosphorylation switches also operate on the interaction interfaces
of folded proteins, hundreds of which were suggested in recent
analysis (Betts et al, 2017).
There is a paucity of information linking phosphorylation
enabled/disabled SLiMs to their binding partners, in part due to a
lack of suitable experimental methods. Although affinity purifica-
tion coupled to mass spectrometry (AP-MS) can be used to obtain
information on phosphorylation states and interactions dynami-
cally, the approach does not provide information with resolution at
the level of the binding sites. In addition, interactions that rely on
SLiMs are often elusive to AP-MS as they typically are of low-to-
medium affinities, and exhibit rapid association/dissociation kinet-
ics. Phosphopeptide libraries can be used to establish preferred
binding motifs of phosphopeptide binding domains, but the
number of sequences presented in these experiments is typically
limited (Yaffe & Smerdon, 2004). In addition, Grossman and co-
workers recently showed the use of yeast-two-hybrid (Y2H) for
capturing phospho-Tyr-dependent interactions (Grossmann et al,
2015), but phospho-dependent interactions are otherwise typically
not captured by Y2H. Thus, there is an urge for novel large-scale
methods for charting phosphorylation-dependent SLiM-based inter-
actions.
Here, we describe a novel large-scale approach termed phospho-
mimetic proteomic peptide-phage display (phosphomimetic ProP-
PD) developed to identify SLiM-based interactions that are regulated
by Ser/Thr phosphorylation. Phosphomimetic ProP-PD is a further
development of ProP-PD, which is a dedicated method for the large-
scale identification of SLiM-based interactions (Ivarsson et al, 2014;
Davey et al, 2017; Wu et al, 2017). We demonstrate that phospho-
mimetic ProP-PD is a straightforward approach for finding ligands
of SLiM-binding domains and for simultaneously pinpointing Ser/
Thr phosphorylation events with potential to enable or disable
interactions. We showcase the approach by identifying phospho-
regulated interactions of PDZ (PSD-95/Dlg/ZO-1) domains, which
are among the most frequent interaction modules in eukaryote
proteomes with about 267 instances in over human 150 proteins
(Luck et al, 2011; Ivarsson, 2012). PDZ domains are well known for
binding to C-terminal peptides with typical PDZ binding motifs
(PDZbms; class I binding motif S/T-x-Φ-coo-, class II Φ-x-Φ-coo-,
and class III D/E-x-Φ-coo-, where x is any amino acid and Φ is a
hydrophobic amino acid), but also interact with internal PDZbms
and phospholipids (Ivarsson, 2012). The last amino acid in the
PDZbm is denoted p0, the upstream residue is denoted p-1, and so
on. Although the PDZbms are the crucial determinants for binding,
residues upstream contribute to the interactions (Tonikian et al,
2008). Based on a limited literature on phospho-regulation of PDZ
domain interactions, phosphorylation of the Ser/Thr at p-2 of the
class I PDZbm typically disables PDZ interactions (Cohen et al,
1996; Chetkovich et al, 2002; Choi et al, 2002; Hu et al, 2002;
Tanemoto et al, 2002; Toto et al, 2017), while phosphorylation of
other positions may either enable or disable interactions (Clairfeuille
et al, 2016).
In this study, we first create a phosphomimetic ProP-PD library
displaying C-terminal regions of the human proteome that contain
known or predicted phosphorylation sites, and the phosphomimetic
mutants of these peptides. Second, we use this library in selections
against the six PDZ domains of human Scribble and DLG1, well-
characterized PDZ proteins with crucial roles in the postsynaptic
density of excitatory neuronal synapses and in the establishment
and maintenance of epithelial cell polarity (Humbert et al, 2008;
Feng & Zhang, 2009). Third, we successfully identify known and
novel interactions, with potential to be regulated by Ser/Thr phos-
phorylation, and uncover that Scribble PDZ interactions are enabled
by p-3 phosphorylation. Finally, we provide the structural basis of
such phosphopeptide binding, expand the analysis to an additional
nine domains, and discuss the role of Ser/Thr phosphorylation as a
switching mechanism of PDZ domain interactions. In this proof-of-
concept study, we thus demonstrate that phosphomimetic ProP-PD
is a powerful approach to identify SLiM-based interactions in the
human proteome that are regulated by Ser/Thr phosphorylation.
The approach is readily scalable and can be used to explore the
potential phospho-regulation of human protein–protein interactions
on a larger scale.
Results
Construction of a phosphomimetic ProP-PD library
To design a specific phage display library for phosphomimetic
ProP-PD, we scanned the human proteome for C-terminal regions
containing known or predicted Ser/Thr phosphorylation sites
based on phosphorylation databases and in silico predictions (see
Materials and Methods). We identified 4,828 unique C-terminal
peptides of human full-length proteins that contain one or multi-
ple potential Ser/Thr phosphosites in their last nine amino acids.
We designed the phosphomimetic ProP-PD library to comprehen-
sively contain wild-type sequences and phosphomimetic mutants
(Ser/Thr to Glu) thereof (7,626 phosphomimetic sequences,
including combinations of multiple phosphorylation sites in one
C-terminus), in order to allow the detection of interactions that
are enabled or disabled by phosphomimetic mutations. The
library design contains 24% of all non-redundant C-terminal
peptides of human full-length proteins reported in the annotated
section of SwissProt/UniProt (Table EV1). Of these sequences,
8.2% contain class I PDZ binding motifs, 6.2% contain class II
binding motifs, and 3.4% match class III binding motifs. In case
of the class I-containing peptides, 40.8% of the phosphorylation
sites are at p-2 and are expected to disable PDZbm-dependent
interactions.
Oligonucleotides coding for the wild-type and phosphomimetic
(Ser/Thr to Glu) peptides flanked by annealing sequences
(Table EV2) were obtained as a custom oligonucleotide library and
incorporated into a phagemid vector, thereby creating C-terminal
fusion proteins of the M13 major coat protein p8, previously engi-
neered for C-terminal display (Fuh et al, 2000; Fig 1). We confirmed
94.6% of the designed sequences by NGS and the vast majority of
reads matched the library design. 62% of raw library sequences
were of right length, and of those, non-synonymous mutations were
present in 14.6% of the sequences. There were no major sequence
biases in the constructed phage library (Fig EV1). The library cover-
age and quality were thus considered satisfactory.
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Phosphomimetic ProP-PD selections against the PDZ domains of
Scribble and DLG1
We tested the performance of the phosphomimetic ProP-PD library
through selections against the immobilized PDZ domains of human
Scribble (PDZ1, PDZ2, and PDZ3) and DLG1 (PDZ1, PDZ2, and
PDZ3). Of these proteins, Scribble has previously been shown to
interact with the p-1 phosphorylated PDZbm of MCC (colorectal
mutant cancer protein; RPHTNETpSL-coo-; Pangon et al, 2012). In
contrast, phosphorylation of the p-2 position has been shown to
disable interaction with DLG1 PDZ2 (Adey et al, 2000). The experi-
ment was thus designed to capture interactions that were enabled or
disabled by phosphomimetic mutations. The selections were
successful as judged by phage pool enzyme-linked immunosorbent
assay (ELISA) and saturated after three rounds of selection. Binding-
enriched phage pools were barcoded and analyzed by NGS, which
resulted in a list of binding peptides ranked by their occurrence in
the NGS results. Although we found increased sensitivity of a
peptide being selected during the phage display if it is well repre-
sented in the naı¨ve phage libraries (see boxplot figures of initial read
support versus being selected or not selected; Fig EV1), there is no
correlation of the selection strength with representation in the naı¨ve
library in any of the experiments reflecting the strong selection
during phage display (Fig EV1).
High-confidence sets of ligands (Fig 2A; Table EV3) were
obtained by assigning cutoff values that filtered out non-specifically
retained peptides lacking typical PDZbms. For each domain, we
generated position weight matrices (PWMs) based on the ProP-PD
(Fig 2B). All domains are class I binding PDZ domains, and the
PWMs are in good agreement with previous studies (Tonikian et al,
2008; Ivarsson et al, 2014; Karlsson et al, 2016).
Analysis of the effects of phosphomimetic mutations
We systematically evaluated the effects of phosphomimetic muta-
tions at distinct positions of the PDZbms by analyzing the NGS
counts received for each peptide pair (wild-type and phospho-
mimetic; Fig 2A). Essentially, we calculated the ratio between the
NGS counts of a given phosphomimetic peptide and the sum of NGS
counts of the phosphomimetic peptide and its wild type
(Table EV3). For comparison between replicate experiments, we
used the fraction of counts, rather than the raw counts, as the total
amount of NGS reads differed between the sequencing rounds. We
then calculated the average ratios for each position of the PDZbm.
This resulted in a score in the range between 0 and 1 for each
peptide position, where 0 indicates that the selection was dominated
by wild-type peptides and suggests that phosphomimetic mutations
at this position disable interactions. A score of 1 suggests that phos-
phomimetic mutations at the given position enable interactions. The
scores for the different domains and peptide positions are summa-
rized in matrices (Fig 2C). Inspection of the NGS frequency of the
wild-type and mutant peptides and the matrices revealed common
and distinct features. Among the shared features is that phospho-
mimetic mutations at p-2 disable interactions with all PDZ domains.
Phosphorylation of this position is thus expected to serve as an “off-
switch” for class I PDZ-mediated interactions. Interestingly, the
analysis suggests that phosphomimetic mutations of the p-3 position
enable interactions, in particular for Scribble PDZ1 and Scribble
PDZ3, for which the differences are statistically significant (Fig 2C,
Table EV4). Phosphomimetic mutations of the upstream positions
5 to 6 have instead negative effects on the interactions. Phospho-
rylation may thus enable or disable PDZ-mediated interactions in a
site-specific manner.
Microscale thermophoresis affinity measurements confirm
phosphorylation switches
To explore the extent to which the phosphomimetic ProP-PD results
translate into affinity differences between unphosphorylated and
phosphorylated peptides, we focused on Scribble PDZ1 ligands. We
selected three distinct sets of peptides (unphosphorylated, phospho-
mimetic mutant, and phosphorylated) for affinity determination by
microscale thermophoresis (MST; Fig 3A). The peptides were
chosen in order to validate the effects of the putative enabling phos-
phorylation switches at the p-1 (MCC; HTNETSL-coo-) and p-3
(RPS6KA2, RLTSTRL-coo-) positions, and the disabling effect of the
upstream p-6 position (TANC1, KRSFIESNV-coo-). Scribble PDZ1
was titrated against FITC-labeled wild-type, phosphomimetic, and
phosphorylated peptides. All peptides bound to Scribble PDZ1 with
micromolar affinities (0.6–101 lM KD values; Fig 3A). Consistent
with the phosphomimetic ProP-PD results, Scribble PDZ1 has a
higher affinity (3×) for the p-1 phosphorylated MCC peptide and the
Figure 1. Schematics of the phosphomimetic ProP-PD approach and
validations.
We designed a phosphomimetic ProP-PD library to display the C-terminal
regions (nine amino acids) of human proteins containing known or putative Ser/
Thr phosphorylation sites (4,827 peptides), and all phosphomimetic (Ser/Thr to
Glu) variants thereof (7,626 peptides). Oligonucleotides encoding the sequences
were incorporated into a phagemid designed for the display of peptides fused to
the C-terminus of the major coat protein P8 of the M13 filamentous phage. The
library was used in binding selections against immobilized PDZ domains.
Binding-enriched phage pools were analyzed by NGS, followed by data analysis
and validations.
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p-3 phosphorylated RPS6KA2 (5×), as compared to their unphos-
phorylated counterparts. The opposite is true for the TANC1 peptide
(2× lower affinity for phosphopeptide; Fig 3A). Thus, there is a good
qualitative agreement between the phosphomimetic ProP-PD data
and the affinity differences between phosphorylated and unphos-
phorylated ligands as determined by MST for this domain. The
A
B C
Figure 2. Analysis of the phosphomimetic ProP-PD selection results.
A Fractions of the sequencing counts for individual peptides (wild-type peptides indicated by red bars and phosphomimetic variants by blue bars) from NGS analysis of
binding-enriched phage pools from selections against the PDZ domains of Scribble and DLG1. Peptides are sorted based on the site of the phosphomimetic mutations
(corresponding to known or putative phosphosites). Standard deviations are indicated (n = 3 for all cases except for Scribble PDZ2 where n = 2). Peptide pairs for
which there are significant differences between the fractions of NGS counts for wild-type and phosphomimetic peptides are indicated with * (multiple t-tests,
significance level 0.05). Peptides with multiple phosphorylation sites have been omitted from this analysis for clarity. For further details, see Table EV3.
B Position weight matrices (PWMs, WebLogo3) representing the phosphomimetic ProP-PD selections data for the PDZ domains of Scribble and DLG1. The numbers of
peptides used for the analysis are indicated.
C Scoring matrices of the effects of phosphomimetic mutations on the phosphomimetic ProP-PD results of the PDZ domains of Scribble and DLG1. Scores are calculated
from the ratios between NGS counts of the phosphomimetic peptides and the sum of the NGS counts of the wild-type and phosphomimetic peptides. A score of 0
(red) indicates that the selection was dominated by wild-type peptides, and a score of 1 (blue) indicates that the selection was dominated by peptides with
phosphomimetic mutations at the given position (n = 3 for all cases except for Scribble PDZ2 where n = 2). Positions marked with * have a score that is significantly
different from the score 0.5 of a neutral effect as determined using multiple t-tests and correcting for multiple comparisons using a false discovery rate of 2.5%. The
position for which only wild-type or phosphomimetic peptides are represented in the data set could not be subjected to this test.
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effects of the phosphomimetic mutations are qualitatively, but not
quantitatively, the same as the effects of ligand phosphorylation,
which is expected due to the distinct properties of Glu in compar-
ison with phospho-Ser/Thr.
To evaluate the effects of ligand phosphorylation on DLG1 PDZ
binding, we determined the affinities for the same set of peptides
with DLG1 PDZ2 (Fig EV2; Table EV5), and found them to be in the
lM range (2.7–95 lM). MST measurements with the p-1 modified
MCC peptides revealed that phosphorylation of this site in this
ligand has a disabling effect on DLG1 PDZ2 interactions (9×; KD
MCC
6.4 lM; KD
pMCC 57 lM). This seemingly contradicts the result
reported in the position-specific matric, but importantly, the MCC
ligand was not identified as a DLG1 PDZ2 in the phage selection,
and it is possible that the results may not be generally extended to
other ligands, as both domains and ligands are flexible and the
results of phosphorylation may depend on the combination of
A
B
C
D E F
G H
I
J
K
Figure 3.
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amino acids at other ligand positions (e.g., the MCC peptide has a L
at p0 instead of the V which is preferred by DLG1 PDZ2). For the p-
3 modified RPS6KA2 peptide (Fig EV2), phosphomimetic mutation
has a minor enabling effect on the interaction (1.3×). Both phospho-
rylation and phosphomimetic mutations of the p-6 position of the
TANC1 peptide have minor disabling effects on DLG1 PDZ 2 binding
(2.9× and 2.4×, respectively), consistent with the phosphomimetic
ProP-PD results.
Isothermal titration calorimetry uncovers entropic–
enthalpic compensation
To further confirm the affinity differences determined for Scribble
PDZ1, and to gain insights into the thermodynamics of the phos-
phopeptide interactions, we performed isothermal calorimetric
(ITC) affinity measurements of Scribble PDZ1 binding to the
unphosphorylated and phosphorylated peptides of MCC (p-1
RPHTNETSL-coo-) and RPS6KA2 (p-3 MKRLTSTRL-coo-; Fig 3B).
In addition, we tested the effect of p-2 phosphorylation using
unphosphorylated and phosphorylated MAPK12 peptides (ARVS-
KETPL-coo-). Consistent with the phosphomimetic ProP-PD and
MST results, phosphorylation of MCC at p-1 has a minor enabling
effect (2× lower KD) on the interactions, and phosphorylation of
RPS6KA2 p-3 has an enabling effect (5×). Phosphorylation at p-2
of MAPK12 disables the interaction, to the extent that no interac-
tion was observed within the concentration range used (25–
2,200 lM), in line with the disabling effect of p-2 phosphorylation
suggested by the phage display.
The differences in Gibbs free energy of binding (DDGphos = DGphos
– DGunphos) between phosphorylated and unphosphorylated peptides
were modest, -0.29 kcal/mol for MCC and -0.89 kcal/mol for
RPS6KA2 (Fig 3C). However, we note an entropy–enthalpy compen-
sation effect between the binding of the unphosphorylated–
phosphorylated peptide pairs. Moreover, the interaction between
Scribble PDZ1 and RPS6KA2 (but not MCC) is associated with
an increase in entropy (TDSRPS6KA2 = 1.6 kcal/mol and
TDSphosRPS6KA2 = 4.8 kcal/mol). This may indicate that the PDZ
domain becomes less rigid upon binding the peptides and/or that
they have pre-formed structures that are broken upon binding, or
that peptide binding is associated with the release of water. Taken
together, affinity measurements through MST and ITC confirm that
phosphomimetic ProP-PD can be used to identify interactions and to
pinpoint putative phosphorylation switches, and the thermodynamic
parameters reveal that the effects of phosphorylation on ligand bind-
ing are more complex than revealed by the modest affinity changes.
NMR structural analysis of Scribble PDZ1 interactions with
unphosphorylated and phosphorylated ligands
To further explore the novel interactions that we identified by phos-
phomimetic ProP-PD and confirmed through MST and ITC, we
determined the NMR structure of the Scribble PDZ1 domain when
bound to the phosphorylated RPS6KA2 (p-3) peptide. We also
performed 15N-1H heteronuclear single-quantum correlation spec-
trum (HSQC) titrations of the RPS6KA2 and MCC peptides (phos-
phorylated and unphosphorylated). The bound Scribble PDZ1
structure has the typical PDZ fold, containing six b-strands and two
a-helices arranged in a sandwich pattern (Fig 3D). The structure
was overall similar to the free protein except for the noticeable
opened binding pocket and the presence of an extended C-terminal
◀ Figure 3. Scribble PDZ1 preferentially interacts with p-1 and p-3 phosphorylated ligands as shown by affinity determinations (MST and ITC), NMR structure,mutational analysis, and GST-pulldowns and co-immunoprecipitation experiments.
A MST affinity measurements using FITC-labeled peptides (unphosphorylated, phosphorylated, and phosphomimetic variants) of MCC (p-1), RPS6KA2 (p-3), and TANC1
(p-6). A fixed peptide concentration (25–50 nM) was titrated with varying concentrations of Scribble PDZ1. KD values were determined using thermophoresis and T-
Jump signal for data analysis (n = 3; error bars represent SD). Statistical assessment using ordinary one-way ANOVA for multiple comparisons confirmed significant
differences (P ≤ 0.001) between the affinities for the phosphorylated peptides compared to the unphosphorylated peptides of MCC, RPS6KA2, and TANC1. For the
comparison between the wild-type and phosphomimetic peptides, there were significant differences for the peptides of MCC (P ≤ 0.01) and RPS6KA2 (P ≤ 0.001), but
not for TANC1. Insets show representative titrations
B Representative ITC titrations of Scribble PDZ1 with unphosphorylated and phosphorylated peptides of MCC, RPS6KA2, and MAPK12 (n = 3). Statistical assessment
using multiple t-tests corrected using the Holm–Sidak method for multiple comparisons show a significant difference between the phosphorylated and
unphosphorylated MCC (P = 0.00098) and RPS6KA2 (P = 0.0003) peptides.
C Differences between the thermodynamic parameters of Scribble PDZ1 when binding unphosphorylated or phosphorylated ligands (MCC and RPS6KA2) as determined
in (B) (error bars represent SD, n = 3).
D Overlay of the previously published unliganded structure of Scribble PDZ1 (gray; PDB code 1X5Q) and the here determined NMR structure (blue; PDB code 6ESP) of
the protein bound to MKRLTpSTRL-coo- (peptide not shown). The canonical PDZ binding grove is indicated by a dotted orange line.
E Structure of the phosphopeptide-bound Scribble PDZ1 showing three positively charged residues (K746, R762, and R801) surrounding the peptide binding pocket.
F Left panel: Equilibrium binding constants for the binding between Scribble PDZ1 wild type and mutants (K746A, R762A, and R801A) and RPS6KA2 (unphosphorylated
and phosphorylated) as determined through ITC titrations (n = 3). Right panel: Changes in the thermodynamic parameters upon mutation (DDHmutation and
TDDSmutation) as determined through ITC (error bars represent SD, n = 3).
G Section of the 15N-1H HSQC spectra of ligand-free wild-type Scribble PDZ1 (red) and the protein bound to the phospho-RPS6KA2 peptide (green), together with the
spectra of the ligand-free R762A mutant (magenta) and the mutant bound to phospho-RPS6KA2 (cyan). Note that residue 762 experiences chemical shift perturbation
only in the wild-type Scribble PDZ1.
H Slice of the 15N-1H HSQC spectra showing the R733 or R762A residue of the wild-type or mutant proteins. R733 is critical for mediating the carboxylate at the C-
terminus, and its position does not change in the wild-type-bound or the R762A-bound form, showing that the carboxylate is still making the important interaction.
I GST-pulldown of full-length Flag-tagged RPS6KA2 wild type and mutants (S730A and S730E) and a truncated version (S730D) over-expressed in HEK293T cells with
GST-tagged Scribble PDZ1. Detection was performed using an anti-Flag antibody.
J Co-IPs of GFP-tagged full-length Scribble with Flag-tagged full-length RPS6KA2 constructs as indicated. Detection was performed using an anti-Flag antibody and an
anti-GFP antibody.
K GST-pulldown of full-length Flag-tagged RPS6KA1 wild type and a truncated version of the protein (S732D). Detection was performed using an anti-Flag antibody.
Source data are available online for this figure.
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region comprising residues 816–829, which is packed onto the b2/
b3 loop. This extended C-terminal region seems to suggest a role of
extra structural elements outside the canonical PDZ fold. This
region was not determined in the free Scribble PDZ1 domain,
perhaps because the sequence used for the structure determination
was shortened at both the C- and N-termini (PDB codes 1X5Q and
2W4F). However, we did not see any 15N-1H chemical shift dif-
ference in the HSQC spectra of the amino acid residues comprising
this region between the free and bound proteins. This suggests that
the extra C-terminal structure is likely present in the free protein too
and might function as an extra scaffold for stability. From the Scrib-
ble PDZ1 HSQC titration spectra, we observed chemical shift pertur-
bations for both the RPS6KA2 and MCC peptides (phosphorylated
and unphosphorylated), further indicating that all four peptides
interact with Scribble PDZ1. The strength of the interactions could
not be determined from these experiments as only two points of
titrations (free and bound) were performed. Nevertheless, it gave
atomic information of the interaction being probed (see below).
The NMR structure was determined with labeled protein and
unlabeled, phosphorylated RPS6KA2 peptide (Table EV6). As
such, only the protein was visible. However, we observed from
the structure that K746, R762, and R801 are all surface-exposed
and around the canonical binding pocket (Figs 3E and EV2). In
addition, the 15N-1H titration experiments revealed that these resi-
dues experienced characteristic shift changes. We hypothesized
that one or a combination of these positively charged residues are
responsible for stabilizing the extra charges brought in by the
phosphate group at position p-3. We therefore introduced single-
point mutations replacing the basic residues with neutral Ala
(K746A, R762A, and R801A) and performed ITC experiments as
above for phosphorylated and unphosphorylated RPS6KA2
peptides. Each of the three substitutions conferred reduced affi-
nities for the phosphopeptide (Fig 3F), with the R762A mutation
having the most pronounced effect on the affinity for phospho-
peptide (6× weaker affinity). The R801A mutation also caused a
reduced affinity for the unphosphorylated ligand and thus affected
peptide binding in general. In contrast, the K746A and R762A
mutations resulted in stronger affinities for the unphosphorylated
ligand; in case of the R762A mutation, phosphorylation has a
disabling effect on ligand binding instead of enabling (Fig 3F).
The ITC results revealed that the effect of the R762A mutation on
phosphopeptide binding is caused by a change in the enthalpic
contribution to binding, and the residue also points into the cavity
likely to be occupied by the phosphate group (Figs 3E and EV3).
The effect of K746A is a bit unclear, but perhaps it plays a role in
steering the charged residues at 6 and 7 of the peptide. This
observation comes from the HSQC titration experiment since both
the phosphorylated and unphosphorylated peptides from MCC and
RPS6KA2 had huge chemical shift perturbation on K746, which is
located at the end of the binding pocket. R801 on the other hand
might play a steering role of both the C-terminal carboxylate and
the phosphate group that are located in its vicinity.
To further explore the effect of the R762A mutation, we
performed 1H-15N HSQC titrations of Scribble PDZ1 R762A and
unphosphorylated and phosphorylated RPS6KA2. The titrations
revealed that the large conformational change exhibited by wild-
type Scribble PDZ1 upon binding phospho-RPS6KA2 is lost in the
R762A mutant (Fig 3G). In contrast, the position of R733, which is
critical for mediating interactions with the carboxylate at the
C-terminus, does not change in the wild-type-bound or the R762A-
bound form, showing that the carboxylate of the peptide is still
making the important interaction (Fig 3H), supporting that the
domain is still functional in binding unphosphorylated and phos-
phorylated RPS6KA2.
Our structural model, titration, and mutagenesis analysis provide
mechanistic insights into how Scribble PDZ1 binds the p-3 phospho-
rylated RPS6KA2 peptide, and establish that R762 can be considered
a gate keeper residue that provides a specificity for the p-3 phospho-
rylated ligand. Analysis of the sign of the NMR chemical shift dif-
ferences can further be used to explore the molecular basis of the
differences between binding the unphosphorylated and phosphory-
lated ligands (Sundell et al, 2018).
GST-pulldown and co-immunoprecipitation of Scribble
and RSK6A2
We next aimed to verify whether the identified interactions and
putative phosphorylation switches are functional in the context of
the full-length proteins focusing on the interaction between Scrib-
ble and RPS6KA2. We performed GST-pulldown experiments
between GST-tagged Scribble PDZ1 and Flag-tagged RPS6KA2 wild
type (WT), phosphomimetic mutant (S730E), Ala mutant (S730A),
and a deletion construct where the three last amino acids had
been truncated (RPS6KA2D). We successfully confirmed an inter-
action with RPS6KA2 S730E, but not with the other constructs,
supporting that the phosphomimetic mutation is required for
interaction (Fig 3I). In addition, we performed co-immunoprecipi-
tations (IPs) of transiently expressed GFP-tagged full-length Scrib-
ble and the Flag-tagged RPS6KA2 constructs and confirmed that
full-length Scribble only shows strong co-IP with the phospho-
mimetic RPS6KA2 S730E (Fig 3J). The results thus support that
phosphomimetic ProP-PD can identify putative phosphorylation-
dependent interactions that are functional in the context of the
full-length proteins.
Although RPS6KA2 S730 is predicted to be autophosphorylated,
there is so far no experimental support for its phosphorylation. In
contrast, the corresponding autophosphorylation site (S732) in the
C-terminal tail (VRKLPSTTL-coo-) of the homologous RPS6KA1 is
a confirmed phosphosite (Dalby et al, 1998). RPS6KA1 was also
found as a Scribble PDZ1 ligand in phosphomimetic ProP-PD
(Fig 2, Table EV3). We therefore determined the affinities of
unphosphorylated and phosphorylated RPS6KA1 peptide for Scrib-
ble PDZ1 through MST using FITC-labeled peptides, resulting in a
KD of 0.39 lM for the phosphorylated RPS6KA1 and 1 lM for the
unphosphorylated peptide (Fig EV2, Table EV5). The results thus
confirm that Scribble preferentially interacts with p-3 phosphory-
lated RPS6KA family members. The RPS6KA1 interaction was
further confirmed through GST-pulldown of Flag-tagged RPS6KA1
(Fig 3K). In this case, the interaction was confirmed in the
absence of a phosphomimetic mutation, which is not surprising
given the high affinity of the interaction with the wild-type
RPS6KA1 peptide. However, phosphorylation of RPS6KA1 p-3 may
serve a switching function as the PDZbm overlaps with an ERK2
binding site, and phosphorylation of p-3 reduces the affinity for
ERK2 binding (Roux et al, 2003), while increasing the affinity for
Scribble PDZ1.
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Comparison between phosphomimetic ProP-PD results and
known ligands
Gene ontology (GO) term enrichment analysis of the identified
ligands (GOrilla, using the library design as background) revealed
enrichment of GO terms related to Hippo signaling (Scribble) and
excitatory chemical synaptic transmission (DLG1), and the ligand
sets thus appear enriched in functionally relevant interactions
(Table EV7). We compared the ligands identified through phospho-
mimetic ProP-PD with the known interactions listed in the HIPPIE
database as of June 2018 (Alanis-Lobato et al, 2017; Fig 4A). HIPPIE
incorporates information from databases such as IntAct (Orchard
et al, 2014) and BioGRID (Chatr-Aryamontri et al, 2015) and
contains already our previously generated ProP-PD results. Of the
Scribble interacting proteins identified in this study, 25% are
reported as Scribble ligands in the HIPPIE database, of which the
evidences in 69% of cases are from our earlier study (Ivarsson
et al, 2014). Among the interactions found through phosphomimetic
ProP-PD, we note the interaction between Scribble and the Hippo
pathway protein WWTR1 (KSEPFLTWL-coo-), which, alongside
YAP1, functions as a transcriptional co-activator downstream of the
Hippo pathway (Moroishi et al, 2015). Interestingly, our results
also suggest that Scribble interacts with YAP1 (DKESFLTWL-coo-),
which provides an additional link to the Hippo signaling pathway.
In addition to the ligands reported in HIPPIE, additional literature
support was found for two of the interactions that were previously
predicted and validated by Luck et al (2011). For DLG1, 32.5% of
the ligands identified through phosphomimetic ProP-PD were
reported in the HIPPIE database, of which 62.5% were also found
in our pilot ProP-PD study. Additional literature support was found
for eight of the DLG1 ligands (Table EV3), among which the inter-
action with APC is of importance for regulating cell cycle progres-
sion (Matsumine et al, 1996).
Most of the ligands previously identified as binders through
ProP-PD but not identified through phosphomimetic ProP-PD were
missing from the novel library design as they did not contain Ser/
Thr phosphorylation sites (89% for Scribble; 86% for DLG1). The
overlap between ProP-PD and phosphomimetic ProP-PD demon-
strate that the method robustly reports on overlapping sets of
ligands despite differences in library designs such as different
peptide length. In addition, phosphomimetic ProP-PD allows the
identification of novel interactions potentially enabled by phospho-
rylation (47% of the novel Scribble ligands, 26% of the novel DLG1
ligands), thereby complementing protein–protein (PPI) data sets
generated by other methods.
Network analysis of ProP-PD results
As confirmed through biophysical experiments, phosphomimetic
ProP-PD provides information on both ligands and phosphorylation
switches. We visualized the multilevel information obtained
through phosphomimetic ProP-PD in a PPI network where we
included the ligands for which we found additional literature
support and/or that share GO terms with the bait proteins that are
unlikely to occur by chance (P < 0.01; Fig 4B). In this network, we
indicate for which PDZ domain the interaction was identified (edge
color), if the phosphomimetic ProP-PD results suggest the interac-
tion to be enabled or disabled by phosphomimetic mutation (above/
below dotted line, respectively), and the position of the known or
putative phosphorylation site (node color).
To present the novel Scribble and DLG1 interactions in a more
functional context, we created a STRING network of the bait
proteins and their ligands, where we included additional proteins if
they have high-confidence connections to the bait proteins or to the
identified ligands. As this network contains too many connections
to be visualized in a meaningful way, we filtered the network for
proteins within KEGG pathways selected based on STRING-based
enrichment analysis (Szklarczyk et al, 2015). In addition to the
previously mentioned Hippo signaling pathway, the network is
enriched in connections to Wnt signaling, oxytocin signaling path-
way, and neuroactive ligand receptor interactions (Fig 4C).
Analysis from the perspective of the kinases
We further evaluated the phosphomimetic ProP-PD data from the
perspective of the kinase that are known or predicted to phosphory-
late the identified ligands (Table EV8), using the NetworKIN algo-
rithm, which takes into account binding motif scores as well as
phylogenetic relationships between kinases and binders and
network proximity in a functional interaction network (Linding
et al, 2007). From this analysis, we found that Scribble PDZ
domains interact with potential RSK, type II receptor Ser/Thr kinase
(ACTR2_ACTR2B_TGFbR2_group), and GSK3 substrates more
frequently than expected when compared to the frequencies of these
kinases’ substrates in the library design (P-values 0.0002 and 0.09
for the other two, respectively, Fisher’s one-sided exact test, BH
correction for multiple testing), although substrates of other kinases
are also represented. Based on the phosphomimetic ProP-PD results,
RSK phosphorylation generally enables Scribble interactions, as is
the case of the autophosphorylation of RPS6KAs, while phosphory-
lation by the ACTR2_ACTR2B_TGFbR2_group disables interactions.
For example, based on the phosphomimetic ProP-PD results and
the NetworKIN predictions, Scribble’s interaction with YAP1 is
proposed to be negatively regulated by p-5 phosphorylation by
TGFbR2. The YAP1 p-5 phosphorylation site has been confirmed
through phosphoproteomics (Kettenbach et al, 2011). Thus, through
a combination of phosphomimetic ProP-PD and bioinformatics, it is
possible to suggest links from the kinase (the writer) to the reader
(the binding domain) that can be further tested in cell-based assays.
The PDZ domains of DLG1 instead preferentially bind to
substrates predicted to be phosphorylated by GRK, PKA, and proto-
oncogene serine/threonine protein (Pim3_pim1_group) kinases
(corrected P-values 0.03), and especially CAM-II substrates (cor-
rected P-value 0.0005). In these cases, phosphorylation is expected
to disable interactions as the phosphomimetic mutations of the resi-
dues confer loss of interactions. Interestingly, the localization of
DLG1 itself has been proposed to be regulated by CAMK2D and they
have been found in complex (Koh et al, 1999).
On the generality of PDZ domains and
phosphopeptide interactions
The literature on ligands containing Ser/Thr phosphorylation sites
that positively regulate PDZ domain interactions is sparse. Through
our study, we found that Scribble PDZ1 interacts with p-1 and p-3
phosphorylated ligands, and the phosphomimetic ProP-PD results
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suggest that Scribble PDZ2 and PDZ3 have similar preferences. We
therefore explored the potential phospho-regulation of the interac-
tions through a qualitative analysis of an additional set of nine class
I binding PDZ domains using our phosphomimetic ProP-PD
approach (Fig 5A and B). As expected, we found that the interac-
tions of all domains tested are negatively affected by
A
C
B
Figure 4. Bioinformatics analysis of Scribble and DLG1 interactions identified through phosphomimetic ProP-PD.
A Overlap between ligands identified through phosphomimetic ProP-PD (red) and interactions reported in the HIPPIE database (blue). The HIPPIE database already
contains ligands previously reported through ProP-PD (green; Ivarsson et al, 2014) for Scribble and DLG1.
B Network representation of high-confidence Scribble and DLG1 ligands. The node color indicates the position of the known or predicted phosphorylation site. Double
mutants are indicated by two colors within one node. The edge color indicates the domain (PDZ1, PDZ2, PDZ3) that was found to interact with the target. The edge
thickness reflects the total count of the peptide (WT and phosphomimetic) in the NGS analysis. For targets above the dotted line, the phosphomimetic mutations
enable interactions. For targets below the dotted line, interactions are disabled by mutations. Interactions with targets on the dotted line are enabled or disabled
depending on which PDZ domain they interact with.
C Extended network containing interactions with STRING score over 0.8 to any target protein that are present in KEGG pathways enriched in the STRING-based
enrichment analysis.
ª 2018 The Authors Molecular Systems Biology 14: e8129 | 2018 9 of 22
Gustav N Sundell et al Phosphomimetic ProP-PD Molecular Systems Biology
Published online: August 20, 2018 
phosphomimetic mutation of p-2. Phosphomimetic mutation of p-1
was beneficial for six domains tested, and of p-3 for two of the
domains (SNTB1 and INADL PDZ6). In contrast, SHANK1 PDZ
interactions were negatively influenced by phosphomimetic muta-
tions of p-3 and p-5. To confirm the disabling effect of p-3 phospho-
rylation on SHANK1 PDZ binding, we determined its affinity for
unphosphorylated and phosphorylated RPS6KA2 peptides through
MST experiments. The results confirmed the disabling effect of p-3
phosphorylation on SHANK1 binding (3.6x; Fig 5). SHANK1 has
previously been shown to interact with RPS6KAs and to be phos-
phorylated by the kinases (Thomas et al, 2005). Our results suggest
that the interaction may be negatively regulated by ligand phospho-
rylation. RPS6Ks also to interact with other PDZ domains such as
Magi PDZ2 that in some cases (e.g., NHERF1) also have been shown
to serve as substrates for the kinases (Thomas et al, 2005; Lim &
Jou, 2016). In case of Magi PDZ2, it was reported that p-3 phospho-
rylation had no effect on PDZ binding (Gogl et al, 2018). Phosphory-
lation of p-3 may thus serve to switch the targets of PDZbms.
Although not identified through phosphomimetic ProP-PD, we also
determined SHANK1 PDZs’ affinity for the p-1 phosphorylated MCC
peptide and found that also this interaction is negatively influenced
by phosphorylation (Fig 5C, Table EV5). Thus, SHANK1 PDZ inter-
actions appear generally negatively regulated by phosphorylation.
We made a structure-based sequence alignment of the here
tested PDZ domains to explore whether the domains that display
the same effect on phosphomimetic mutations share common
features on the primary sequence level (Fig 5D). In this alignment,
we also included the PDZ domain of SNX27, as it was recently
reported that ligand phosphorylation (p-3, p-5 or p-6) reinforces its
interactions (Clairfeuille et al, 2016). In the alignment, we indicated
the residues corresponding to Scribble R762 that we showed is a
gatekeeper for Scribble PDZ1’s interaction with the p-3 phosphory-
lated ligand. A basic residue (Arg/Lys) on the corresponding site is
present also in SNTB1 and in Scribble PDZ2 and PDZ3 that display a
similar pattern of regulation. The presence of a basic residue in this
position may thus serve as an indication of putative phosphopeptide
binding PDZ domains. Along these lines, a Lys at the corresponding
position was previously implicated in the interaction between Tiam1
PDZ and the p-1 Tyr phosphorylated class II binding peptide of
syndecan1 (Liu et al, 2013). However, the basic residue is missing
in other phosphopeptide PDZ domains such as SNX27 PDZ. SNX27
PDZ has instead an Arg in b2 (corresponding to Scribble A743; indi-
cated in the alignment) that directly lines the peptide binding pocket
and is involved in stabilizing the phosphate group of p-3, p-5, or p-6
phosphorylated ligands through a network of residues (Clairfeuille
et al, 2016). The SNX27 PDZ domain and Scribble PDZ1 thus
accomplish p-3 phosphorylated ligand binding in distinct manners.
To explore the plasticity of the phosphopeptide binding, we intro-
duced an Arg in b2 (A743R) in the background of Scribble PDZ1
R762A, which has a preference for unphosphorylated ligands. We
determined the affinities for the phosphorylated and unphosphory-
lated MCC (p-1) and RPS6KA2 (p-3) peptides through ITC (Fig 5E;
Table EV5). We found that the R762A/A743R mutation did not
confer any specificity for the p-1 phosphorylated MCC peptide, but
it restored a preference for p-3 phosphorylated RPS6KA2. Thus, the
specificity of Scribble PDZ1 for phosphopeptides can easily be
tuned, and it is likely that this plasticity for phosphopeptide binding
is shared with several other members of the PDZ domain family. As
the specificity of PDZ domain interactions depends on both direct
and indirect interactions (Ernst et al, 2014) and there are multiple
ways of the domains to accomplish phosphopeptide binding, it is
difficult to draw general conclusions based on the analysis of the
primary sequences.
Pre-phosphorylation ProP-PD
One alternative strategy to identify phosphorylation switches
through phage display is to treat the phage library with a kinase
prior to phage display selection (Fig 6A). Such a strategy has previ-
ously been used to identify ligands of a pTyr binding PTB domain
(Dente et al, 1997). To evaluate this approach in comparison with
phosphomimetic ProP-PD, we first generated a library that displays
the wild-type peptides of the phosphomimetic ProP-PD design (98%
of the design was confirmed by NGS). Aiming to test the approach
against the bait protein Scribble PDZ1, we then treated this wild-
type library with RPS6KA1 and validated the library phosphoryla-
tion using a monovalent phospho-Ser-specific antibody (Fig 6B).
Finally, we used the phosphorylated and unphosphorylated library
in parallel selections against Scribble. Pooled phage ELISA indicated
that the selections were successful, and the binding-enriched phage
pools were analyzed through NGS (Fig 6C).
Analysis of the enriched peptide sequences revealed that there
was no or little difference in terms of the identity of the enriched
ligands between the selections. However, there are some significant
differences between the two sets. In particular, the TMFLRETSL-
coo- peptide of GUCY1A2 obtained significantly larger proportion of
the NGS counts in the selection against the pre-phosphorylated
library than in selections against the unphosphorylated library (3×).
Interestingly, the peptide contains a “R..S” sequence that matches
the preferred RPS6KA1 phosphorylation motif (Romeo et al, 2012).
Thus, it is plausible that the kinase treatment leads to a phosphory-
lation of GUCY1A2, which gives a selective advantage consistent
with the results of the phosphomimetic ProP-PD. The MAPK12
peptide obtained instead a lower proportion of the NGS counts in
the selection against the phosphorylated library, which is likely
explained by the fact that it is outcompeted by the phosphorylated
GUCY1A2 peptide, as the MAPK12 peptide lacks a suitable RPS6KA1
phosphorylation motif. The results of the phage display in combina-
tion with kinase treatment are in good agreement with the results
of the phosphomimetic ProP-PD. Indeed, the phosphomimetic
TMFLRETEL-coo- peptide dominated the selection against Scribble
PDZ1 and occurred three times more than its wild-type counterpart
(Fig 2A). Thus, the tandem combination of phosphomimetic ProP-
PD and pre-phosphorylation ProP-PD can be a viable approach for
identification and validation of phospho-regulated interactions.
Discussion
In this study, we aimed to test the feasibility of phosphomimetic
ProP-PD for the identification of interaction that are regulated by
Ser/Thr phosphorylation. We created a phage display library
comprising C-terminal peptides in the human proteome with known
or putative Ser/Thr phosphorylation sites, and phosphomimetic
variants thereof. We demonstrated the power of using such a phos-
phomimetic ProP-PD library together with NGS to identify
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Figure 5. Qualitative effects of phosphomimetic mutations on interactions with a variety of class I binding PDZ domains as determined by phosphomimetic
ProP-PD, together with analysis of the plasticity of the interactions of Scribble PDZ1 with phosphorylated ligands.
A Phosphomimetic ProP-PD selection results from selections against nine additional class I binding PDZ domains. The fractions of the sequencing counts from NGS
analysis of the binding-enriched phage pools for each peptide wild-type and phosphomimetic peptide pair (wild type in red bars and phosphomimetic peptide in
blue). The site of the phosphomimetic mutations is indicated below the peptide sequences. Peptides with multiple phosphorylation sites have been removed for
clarity.
B Scoring matrices of the effects of phosphomimetic mutations on the phosphomimetic ProP-PD results of the PDZ domain scores are calculated from the ratios of NGS
counts of the phosphomimetic peptides and the sum of the NGS counts of the wild-type and phosphomimetic peptides. A score of 0 (red) indicates that the selection
was dominated by wild-type peptides, and a score of 1 (blue) indicates that the selection was dominated by peptides with phosphomimetic mutations at the given
position.
C MST affinity measurements using FITC-labeled peptides (unphosphorylated, phosphorylated, and phosphomimetic) of MCC (p-1) and RPS6KA2 (p-3) and SHANK1 PDZ.
A fixed peptide concentration (25–50 nM) was titrated with varying concentrations of the protein. KD values were determined using thermophoresis and T-Jump
signal for data analysis (n = 3; error bars represent SD). Statistical assessment using ordinary one-way ANOVA for multiple comparisons confirmed significant affinity
differences between wild-type and phosphomimetic RPS6KA2 (P ≤ 0.01) and unphosphorylated and phosphomimetic or phosphorylated MCC (P ≤ 0.001).
D Structure-based sequence alignment of the PDZ domains explored in this study and SNX27 PDZ that was recently shown to bind phosphopeptides (Clairfeuille et al,
2016). The numbering is based on Scribble, and the sequences are ordered based on sequence similarities with Scribble PDZ1. The red boxes indicate the basic
residues of Scribble PDZ1 mutated in Fig 3, and residue A743, which aligns with the R58 of the SNX27 PDZ domain that was recently described to be of importance
for binding p-3 and p-5 phosphorylated ligands.
E Histogram of equilibrium dissociation constants of Scribble PDZ1 R762A (mutational background) and the R762A/A743R mutant with unphosphorylated and
phosphorylated MCC and RPS6KA2 peptides (error bars represent the SD, n = 3). Note that the A743R mutation restores the preference for the p-3 phosphorylated
RPS6KA2 peptide.
ª 2018 The Authors Molecular Systems Biology 14: e8129 | 2018 11 of 22
Gustav N Sundell et al Phosphomimetic ProP-PD Molecular Systems Biology
Published online: August 20, 2018 
interactions of potential biological relevance that can be enabled
and disabled by Ser/Thr phosphorylation. From the perspective of
PDZ domains, we provide evidences for a dynamic switch-like
mechanism, where phosphorylation at p-1 or p-3 enables interac-
tions with Scribble PDZ domains, while disabling interactions
with other PDZ domains, such as SHANK1 PDZ. Such effects are
likely to be of functional importance in a cellular complex where
the composition of PDZ protein complexes is determined by the
dynamic equilibriums between the relative affinities of the inter-
acting proteins and the relative protein concentrations. Based on
our results, we expect that phosphorylation switches of PDZ
domain interactions will be more common than previously appre-
ciated.
The rationale behind using Glu as a mimetic mutation of pSer/
pThr is that Glu (or Asp) is negatively charged and is nearly iso-
steric with pSer and pThr (Pearlman et al, 2011). Phosphomimetic
mutations have frequently been used to study the effects of phos-
phorylation since it was shown that replacing a phosphoserine with
an Asp mimicked the phosphorylated state of a protein (Thorsness
& Koshland, 1987). It also appears as if nature has made use of the
reverse engineering by evolving phosphosites from acidic amino
acids (Pearlman et al, 2011). It has, however, been less common to
use phosphomimetic mutations to study the effects of phosphoryla-
tion on a ligand binding site. The success of the approach will
depend on the nature of the interactions studied.
On the one side, phosphomimetic mutations serve a qualitative
purpose when the intention is to investigate a general charge-
dependent interaction although the quantitative effects are not
expected to be identical given the differences in net charge at
physiological pH (Glu -1, pSer/pThr -2; Cooper et al, 1983) and
the differences in hydration shells (Hunter, 2012). Along these
lines, we found the effects of phosphomimetic mutations and
ligand phosphorylation on PDZ binding to be consistently
enabling or disabling depending on the ligand position, although
the absolute numbers differed in terms of effects on KD values.
Similar results were reported in a recent study on the effect of p-
2 phosphorylation of the EQVSAV-coo- peptide of on binding to
the second PDZ domain of PTBL (Toto et al, 2017). In a similar
fashion, acidic amino acids or phospho-Ser downstream of the
core docking motif of the regulatory subunit B56 of protein phos-
phatase 2A (L..I.E.) enhances the affinity of the interaction, as
also shown by ProP-PD (Hertz et al, 2016; Wu et al, 2017). The
phosphomimetic ProP-PD approach should thus be applicable to
other cases, for which negative charges contribute to the binding
affinity but where there is no strict requirement on phosphoryla-
tion. For example, the WD40 repeats form versatile interaction
modules that are among the most abundant protein domains.
They could represent suitable bait proteins for phosphomimetic
ProP-PD as phosphomimetic mutations have been found to enable
interactions with WD40 repeat of UAF1 (Villamil et al, 2012) and
bTrCP (da Silva Almeida et al, 2012).
On the other side, when it comes to a highly specific phospho-
binding site, there is often a strong dependency on the geometry of
the Args (or other residues) that line the binding pocket. For exam-
ple, the FHA domain of Rad53p requires the presence of phospho-
Thr and does not tolerate phospho-Ser or Glu (Durocher et al,
1999). For such cases, phosphomimetic mutations are bound to fail.
Phosphomimetic mutation has also been found to be less suited for
mimicking Ser phosphorylation of the second position of the PP2A
B56 binding motif, as its phospho-Ser binding involves specific
interactions with an Arg that is too far away to be reached by a
phosphomimetic mutation (Wang et al, 2016). Another example for
which a phosphomimetic mutation has been shown to fail to mimic
the effect of phospho-Ser involves 14-3-3f (Zheng et al, 2003).
A
B C
Figure 6. Pre-phosphorylation ProP-PD confirms phospho-regulation of
the interactions of Scribble PDZ1.
A We constructed a ProP-PD library that displays peptides that represent the
C-terminal peptides of the human proteome with known or putative Ser/
Thr phosphorylation sites (i.e., the wild-type part of the phosphomimetic
ProP-PD library design). The library was subjected to phosphorylation by
RPS6KA1 prior to each round of selection against the bait Scribble PDZ1.
The binding-enriched phage pools were analyzed by NGS, and the results
were compared to the results of a selection against the same library but
without phosphorylation.
B Phosphorylation of the ProP-PD library was confirmed through sandwich
ELISA. An anti-phospho-Ser/Thr/Tyr antibody was immobilized and
challenged with the phosphorylated or unphosphorylated ProP-PD library,
and the binding was detected using an HRP-conjugated anti-M13 antibody
(error bars represent SD, n = 2). A significant difference in the binding to the
phospho-antibody was observed for the phosphorylated ProP-PD library as
compared to unphosphorylated library (*P ≤ 0.05, unpaired t-test).
C Bar graphs representing the fraction of NGS counts for distinct peptides
from the selections against the pre-phosphorylated and unphosphorylated
libraries (error bars represent SD, n = 2). For peptides indicated with *,
there are significant differences between the fractions of NGS counts from
the distinct selections, using multiple t-tests.
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However, more recently it was found that a phosphomimetic RxEP
motif in the NS3 protein of dengue virus interacts with 14-3-3e
(Chan & Gack, 2016). Given the versatility of the binding mode of
the 14-3-3 proteins, it is possible that the results will depend on the
overall context of the peptide subjected to phosphomimetic
mutation. To explore the full potential of phosphomimetic ProP-PD,
it will be necessary to design follow-up studies with more
complex ProP-PD libraries and to challenge it with a variety of bait
proteins.
We further made an attempt to compare phosphomimetic
ProP-PD to the pre-phosphorylation ProP-PD where the phage
library is phosphorylated with a given kinase prior to selection,
which confirmed phospho-regulation of the Scribble PDZ1 binding
TMFLRETSL-coo- peptide of GUCY1A2 by RPS6KA1. The
approaches could thus be used in tandem. However, the pre-phos-
phorylation approach would benefit from further optimization.
Among the limitations of the approach, as we see it, is that it is
unclear what percentage of the phage library is phosphorylated, in
particular when using a multivalent display on the major coat
protein p8. Furthermore, some peptides contain multiple potential
phosphorylation sites, and it might become difficult to distinguish
exactly what phosphorylation event is responsible for a shift in
the enriched peptides. A more sophisticated approach to tackle
PTM-dependent interactions would be to use an expanded genetic
code, where an amber stop codon is used to encode a twenty-first
additional amino acid. Given that an expanded genetic code has
been used for protein evolution experiments with several unnatu-
ral amino acids (Liu et al, 2008) and that optimized orthogonal
aminoacyl-tRNA synthetase/tRNACUA pairs for phospho-Ser and
phospho-Thr incorporation were recently generated (Rogerson
et al, 2015; Zhang et al, 2017), such an approach should be feasi-
ble and is likely to become a viable approach in specialized
laboratories. For such a setup, it will be crucial to ensure that the
full-length phospho-Ser-containing peptides are produced and
displayed at the same level as other peptides and that the
phospho-Ser displaying phage do not suffer any growth disadvan-
tage. On a related note, in a recent study they encoded human
phospho-Ser-containing peptides in bacteria for profiling of phos-
pho-dependent interactions (Barber et al, 2018). Thus, this and
other emerging approaches will be of complementary use for
finding phosphorylation-dependent interactions. Among the
methods, phosphomimetic ProP-PD offers an efficient approach for
detecting potential phosphorylation switches without the require-
ment of the usage of alternative codons or optimization of proto-
cols and thus offers a straightforward and attractive approach of
broad applicability for exploring the potential phospho-switching
of motif-based interactions.
The focus of this study is on the C-terminal regions of the
proteome, and interactions with PDZ domains, but it can be envi-
sioned to create libraries that cover a large proportion of the Ser/
Thr phosphosites in the disordered regions of the human proteome.
Further studies with more extensive phosphomimetic ProP-PD
libraries and alternative sets of phosphopeptide binding domains
will establish the general applicability of the approach. We expect
that the approach will prove to be feasible for probing phospho-
regulated interactions on a large scale, in particular for domains that
have an inherent affinity for their unphosphorylated ligands that is
enhanced by the addition of the extra charges. The approach also
offers an efficient way to pinpoint interactions that are negatively
regulated by ligand phosphorylation. As discussed, the method is
less suited for proteins with strict requirement on the phosphate
group for binding. In an expanded form, phosphomimetic ProP-PD
can be a highly useful tool for assigning functional roles to the phos-
phoproteome, and for linking of phosphorylation switched SLiMs to
their respective binding domains, thereby contributing to solving
the phosphorylation code.
Materials and Methods
Reagents and tools table
Reagent/Resource Reference or Source Identifier or catalog number
Experimental models
HEK293 Human embryonic kidney cells Sigma Aldrich 85120602
E. coli SS320 Lucigen 60512-1
E. coli omniMAX Fisher Scientific C85812-01
E. coli BL21(DE3) Sigma Aldrich CMC0014
Recombinant DNA
pDONR223-RPS6KA2 Addgene (Johannessen et al,
2010)
# 23530
pKH3-human RSK1 Addgene (Richards et al, 2001) # 13841
p3XFLAG-CMVª-10 Expression Vector Sigma Aldrich E7658
GFP-tagged full-length human Scribble JP Borg (INSERM Marseille) N/A
Scribble PDZ1 petM11 PDZ1 aa 719-829 Human Ivarsson et al (2014) N/A
Scribble PDZ1 pGEX Human Tonikian et al (2008) N/A
Scribble PDZ2 pGEX Human Tonikian et al (2008) N/A
Scribble PDZ3 pGEX Human Tonikian et al (2008) N/A
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Reagents and Tools table (Continued)
Reagent/Resource Reference or Source Identifier or catalog number
DLG1 PDZ1 pGEX Human Tonikian et al (2008) N/A
DLG1 PDZ2 pGEX Human Tonikian et al (2008) N/A
DLG1 PDZ3 pGEX Human Tonikian et al (2008) N/A
NHREF3:4 pGEX Human Tonikian et al (2008) N/A
Magi1 PDZ4 pGEX Human Tonikian et al (2008) N/A
DLG3 PDZ2 pGEX Human Tonikian et al (2008) N/A
DLG4 PDZ3 pGEX Human Tonikian et al (2008) N/A
Inadl PDZ6 pGEX Human Tonikian et al (2008) N/A
MPDZ PDZ10 pGEX Human Tonikian et al (2008) N/A
SHANK1 PDZ pGEX Human Tonikian et al (2008) N/A
SNTA1 PDZ pGEX Human Tonikian et al (2008) N/A
SNTB1 PDZ pGEX Human Tonikian et al (2008) N/A
DLG1 PDZ 2 311–407 in a modified pRSET vector 40 Human Chi et al (2009) N/A
M13 major coat protein P8 phagemid Held and Sidhu (2004) N/A
Antibodies
Rabbit anti-FLAG Abcam Cat # ab 1162
Rabbit anti-GFP Abcam Cat # ab 6556
Rabbit anti-beta Actin Abcam Cat # ab 1801
HRP-conjugated anti rabbit secondary antibody Life Technologies ref # G21234
HRP-ANTI-M13 monoclonal conjugate GE Healthcare 27-9421-01
Mouse Anti Phospho Ser/Thr/Tyr antibody Invitrogen MA1-38450
Oligonucleotides and sequence-based reagents
Library primers This study Table EV2
AATGATACGGCGACCACCGAGATCTACACTCTTTCCCTACACGACGCTCTTCCGATCT(8 NT
barcode)TATGCAGCCTCTTCATCTGGC
This study N/A
CAAGCAGAAGACGGCATACGAGCTCTTCCGATCT(6 NT barcode)CCTCCGGATCCTCCACC This study N/A
CGAAGGCATCTTCATCTCTGCTGTGTCTGAAGAAGGTCC This study R7762A Scribble PDZ1 F
GGACCTTCTTCAGACACAGCAGAGATGAAGATGCCTTCG This study R7762A Scribble PDZ1 R
CATCGCCGGCGGTGCAGGCTCCACTCC This study K746A Scribble PDZ1 F
GGAGTGGAGCCTGCACCGCCGGCGATG This study K746A Scribble PDZ1 R
GTCTGGGTATCAGCATCAGAGGCGGTAAAGGCTCCAC This study A743R Scribble PDZ1 F
GTGGAGCCTTTACCGCCTCTGATGCTGATACCCAGAC This study A743R Scribble PDZ1 R
CAGTAGAAGCGCTGGCTGGTGCGGGCACTG This study R801A Scribble PDZ1 F
CAGTGCCCGCACCAGCCAGCGCTTCTACTG This study R801A Scribble PDZ1 R
GTGAAGCTTATGGACCTGAGCATGAAGAAGTTCGC This study KS6A2 cloning primer F
CTAGAATTCACAACCGCGTGGACGTGAGTCTCTTC This study KS6A2 cloning primer R
CTAGAATTCACAACCGCGTCTCCGTGAGTCTCTTC This study KS6A2RS>E cloning primer R
CTAGAATTCACAACCGCGTGGCCGTGAGTCTCTTC This study KS6A2RS>A cloning primer R
TCCGAATTCATGCCGCTCGCCCAGCTCAAGGAGCC This study KS6A1 cloning primer F
CCTGATATCACAGGGTGGTGGATGGCAACTTCCTC This study KS6A1 cloning primer R
CCTGATATCGGCCATCGATCAGGATGGCAACTTC This study KS6A1-TTL cloning primer R
CTAGAATTCGAAAGTTGGGTATCAGGACGTGAGTCTC This study KS6A2-TRL cloning primer R
CCTGATATCACAGGGTGGTCTCTGGCAACTTCCTC This study KS6A1R1E cloning primer R
CCTGATATCACAGGGTGGTGGCTGGCAACTTCCTC This study KS6A1R1A cloning primer R
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Reagents and Tools table (Continued)
Reagent/Resource Reference or Source Identifier or catalog number
Chemicals, enzymes and other reagents
T4 PNK Fisher Scientific 10531061
T7 pol, 300 units Fisher Scientific 10529710
T4 DNA ligase Fisher Scientific 10723941
Exonuclease I VWR E70073Z
Hypure molecular biology grade water GE healthcare SH30538.03
Shrimp alkaline phosphatase, 1,000 units VWR E70092Z
Phusion Fisher Scientific 10402678
DNASE I 1 × 100 mg vwr A3778.0100
Glutathione Magnetic Beads 20 ml Fisher Scientific 11834131
Anti-FLAG® M2 Magnetic Beads Sigma Aldrich M8823
FITC-HTNETEL GeneCust N/A
FITC-HTNETSL GeneCust N/A
FITC-HTNETpSL GeneCust N/A
RPHTNETSL GeneCust N/A
RPHTNETpSL GeneCust N/A
MKRLTSTRL GeneCust N/A
MKRLTpSTRL GeneCust N/A
FITC-RLTSTRL GeneCust N/A
FITC-RLTETRL GeneCust N/A
FITC-RLTpETRL GeneCust N/A
FITC-KRSFIESNV GeneCust N/A
FITC-KREFIESNV GeneCust N/A
FITC-KRpSFIESNV GeneCust N/A
ARVSKETPL GeneCust N/A
ARVSKEpTPL GeneCust N/A
CompleteTM, EDTA-free Protease Inhibitor Cocktail Sigma Aldrich 4693132001
DMEM, high glucose, GlutaMAXTM Supplement Fisher Scientific 61965026
Fetal Bovine Serum, qualified, US origin Fisher Scientific 26140087
MEM Non-Essential Amino Acids Solution (100×) Fisher Scientific 11140035
Trypsin-EDTA (0.5%) Fisher Scientific 15400054
Fugene HD Promega E2311
HindIII Fisher Scientific ER0501
RPS6KA1 Thermo Fisher PV3680
EcoRI Fisher Scientific ER0271
AcTEV Fisher Scientific 10216572
SmaI fast digest Fisher Scientific 10324630
Taq DNA Polymerase VWR 733-1819
Software
Cytoscape v3.6.1 http://www.cytoscape.org
Shannon et al (2003)
R 3.4.2 R Core Team (2017) https://www.
R-project.org/
STRING 10.2 Szklarczyk et al Nucleic Acids Re
s. 2015 43(Database issue):D447-
52
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Reagents and Tools table (Continued)
Reagent/Resource Reference or Source Identifier or catalog number
Networkin 3.0 Horn et al, KinomeXplorer: an
integrated platform for kinome
biology studies. Nature Methods
2014;11(6):603–604
Perl v5.18.2 http://www.perl.org/
PRISM 6 https://www.graphpad.c
om/support/prism-6-updates/
Netphos 3.2 Blom et al (2004)
Origin 7 OriginLab corporation
MO. Affinity Analysis v2.1.2 NanoTemper
Venn Diagram http://bioinformatics.psb.uge
nt.be/webtools/Venn/
Other
Monolith NT automated MST NanoTemper
ITC200 Malvern Instruments
1× MiSeq sequencer (Illumina) Illumina
NMR 600, and 900 MHz Bruker
Library design
The phosphomimetic ProP-PD library was designed to contain C-
terminal peptides of the human proteome with known and predicted
phospho-Ser/Thr sites.
1 Select human C-terminal (9mers) sequences from human
SwissProt/UniProt containing known Ser or Thr phosphosites
from PhosphoSite (Hornbeck et al, 2004, 2015), Phospho-
ELM (Dinkel et al, 2011), and NetPhos 3.1 (Blom et al, 2004).
For this study, the data were downloaded on October 10, 2013.
2 Design a phage library that contains all the selected wild-type
sequences and phosphomimetic variants thereof (Ser/Thr to
Glu). Add combinatorial entries in case of multiple predicted or
measured sites: If, for example, two phosphorylation sites (A
and B) are found in the same sequence, add pA+Bw, Aw+pB,
and pA+pB (where “p” denotes the phosphomimetic variant
and w the wild type). The design for this study contains a total
of 12455 entries (Table EV1). In case of the Phospho-ELM and
NetPhos predictions, kinase information is provided in the
library design file when available.
3 Generate the oligonucleotide sequences required for library
construction by reversely translating the peptide sequences
using codons optimized for E. coli expression. Add flanking
annealing sites complementary to the phagemid vector
(Table EV2).
Library construction
The M13 phage library was constructed based on a phagemid
coding for M13 major coat protein p8 modified for C-terminal
peptide display (Held & Sidhu, 2004), and with a SmaI restriction
site added between the annealing sites used for library construc-
tion.
1 Produce single-stranded DNA as described in Rajan and Sidhu
(2012).
2 Amplify the obtained oligonucleotide library (CustomArray) by
PCR using Phusion DNA polymerase according to the protocol
(Thermo Scientific). Remove residual single-stranded DNA
(ssDNA) by ExoI treatment (0.2 units/ll, 37°C for 30 min, 85°C
for 15 min) followed by flash-cooling on ice. Purify the PCR
product with QIAquick Nucleotide Removal Kit (Qiagen). Quan-
tify the PCR product using PicoGreen dsDNA quantitation assay
(Thermo Fisher).
3 Phosphorylate 0.6 lg of the PCR product with 20 units of T4
polynucleotide kinase for 1 h in TM buffer (10 mM MgCl2,
50 mM Tris–HCl, pH 7.5) supplemented with 1 mM ATP and
5 mM DTT.
4 Directly after phosphorylation, anneal the primers to 20 lg of
the ssDNA phagemid (90°C for 3 min, annealing at 50°C for
3 min and 20°C for 5 min) in TM buffer in a total volume of
250 ll.
5 Synthesize dsDNA by the addition of 10 ll 10 mM ATP, 10 ll
10 mM dNTP, 15 ll 100 mM DTT, 30 Weiss units of T4 DNA
ligase, and 30 units of T7 DNA, at 20°C for 16 h. Stop the reac-
tion by freezing the reaction mixture (20°C).
6 Thaw the sample and digest wild-type DNA using SmaI
(Thermo Fisher) for 3 h at 30°C.
7 Purify the dsDNA by QIAquick DNA purification kit (Qia-
gen). Elute it with 35 ll ultrapure H2O (HyPure; GE Health-
care).
8 Electroporate the purified dsDNA into E. coli SS320 (Lucigen)
preinfected with M13KO7 helper phage (New England Biolabs;
for preparation of the bacteria, see Rajan & Sidhu, 2012) using a
Gene Pulser (Bio-Rad) electroporation system at an electric
potential of 2.5 kV, a capacitance of 25 lFD, and a resistance of
100 Ω.
9 Immediately add the bacteria to 25 ml preheated SOC media
(0.5 W/V% yeast extract, 2 W/V % tryptone, 10 mM NaCl,
2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, and 20 mM
glucose), and incubate for 30 min.
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10 Determine the electroporation efficiency by titering the
phagemid containing bacteria through serial dilutions. Sample
10 ll of the bacterial culture and make 10× serial dilutions in
2YT (0.5 W/V% NaCl, 1 W/V% yeast extract, and 1.6 W/V%
tryptone). Spot 5 ll/dilution of each dilution on LB agar plates
supplemented with 100 lg/ml carbenicillin. Incubate the plates
overnight at 37°C. Count the number of colonies. For this study,
the transformation efficiencies were 5 × 106 transformants for
the phosphomimetic ProP-PD library and 1 × 106 transformants
for the wild-type library, which more than 100-fold exceeds the
number of unique sequences in the library design.
11 Add the bacterial culture (from point 10) to 500 ml 2YT and
incubate overnight at 37°C with shaking.
12 Pellet the bacteria (15 min, 3,500 g) and transfer the phage
supernatant to new centrifugal tubes containing one-fifth the
final volume of PEG/NaCl (20% PEG 8000, 400 mM NaCl) for
precipitation of the phage. Incubate for 5 min on ice and pellet
the phage by centrifugation (25,000 g for 20 min) at 4°C.
13 Resuspend the phage pellet in 10 ml phosphate-buffered saline
(PBS; 37 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, and 2 mM
KH2PO4), pH 7.4, with 0.05% Tween-20.
14 Remove insoluble debris by centrifugation for 10 min at
25,000 g. Transfer the phage solution to a clean Falcon tube.
15 Supplement the library with 20% (vol/vol) glycerol, and store it
at 80°C.
16 Estimate the phage concentration by infecting actively growing
E. coli OmniMAX (OD600 = 0.6) with serial dilution of the library.
Spot 5 ll of each dilution on LB agar plates supplemented with
100 lg/ml carbenicillin, and incubate overnight. The phage
concentration of the phosphomimetic library was estimated to be
1010 colony-forming units (cfu)/ll, and the concentration of the
wild-type library was estimated to be 1.8 × 109 cfu/ll.
Protein expression and purification
Glutathione transferase (GST)-tagged PDZ domains and GST for
phage display selections were expressed and purified as described
previously (Tonikian et al, 2008; Ivarsson et al, 2014). Protein
expression for MST, ITC, and NMR experiments was as follows:
Plasmids encoding His-tagged proteins (human Scribble PDZ1 aa
719–829 in pETM-11, human DLG1 PDZ2 aa 311–407 in a modified
pRSET vector 40, or human Shank1 PDZ aa 652–761 in pETM-33)
were transformed into E. coli BL21 Gold (DE3; Agilent), and the
proteins were expressed in 2YT media supplemented with appropri-
ate antibiotic (70 or 100 lg/ml carbenicillin). Protein expression
was induced upon reaching an OD600 of 0.8 by adding 1 mM
isopropyl b-D-1-thiogalactopyranoside (IPTG) final concentration
and allowed for 4 h at 30°C.
Scribble PDZ1 for NMR experiments was expressed in M9 salt
enriched with 13C D-glucose and 15N ammonium chloride. Bacteria
were harvested by centrifugation at 10,000 × g for 20 min at 4°C.
The pellets were resuspended in PBS supplemented with 5 mM
CaCl2, 10 lg/ml DNaseI, and 1 mg/ml lysozyme and protease inhi-
bitor (cOmplete Mini EDTA-free; Sigma-Aldrich) and incubated for
1 h at 4°C. The lysates were subjected to sonication in 1- to 3-s
pulses for 20 pulses. The lysate was cleared by centrifugation at
20,000 × g for 1 h. The cleared lysates were supplemented with
20 mM imidazole and incubated 1 h with Ni2+ Sepharose resin (GE
Healthcare). The resin was washed with PBS and 50 mM imidazole,
pH 7.4. Bound proteins were eluted in PBS with 300 mM imidazole
and dialyzed to appropriate experimental buffers using SnakeSkin
dialysis membrane (50 mM Tris–HCl, pH 7.4, for MST; and 20 mM
HEPES, pH 7.4, for ITC).
For MST affinity measurements involving SHANK1 PDZ, the His-
GST-tag was removed using GST-tagged HRV3C protease. The
protein was mixed with 1:100 (w/w) HRV3C protease and dialyzed
overnight into PBS (pH 7.4) containing 10 mM MgCl2, 0.05%
Tween-20, and 1 mM B-mercaptoethanol. The following day, the
cleaved His-GST tag and the GST-HRV3C protease were removed
using Glutathione Sepharose 4B resin (GE Healthcare), and the
supernatant containing untagged SHANK1 PDZ was collected.
For NMR experiments, we cleaved the His-tag of the labeled
protein overnight at 8°C with 0.1 lg of His-tagged TEV protease per
mg Scribble PDZ1, while dialyzing in 50 mM Tris–HCl (pH 8.0),
0.5 mM EDTA, and 1 mM DTT. The untagged Scribble PDZ1 was
collected as a flow in an Ni2+ Sepharose column and was dialyzed
into 10 mM NaPO4, pH 6.8. The sample was flash-frozen and stored
at 20°C until further use.
Phosphorylation of wild-type ProP-PD library
For pre-phosphorylation of the wild-type ProP-PD library, we
obtained activated RPS6KA1 (Thermo Fisher). The time and amount
of kinase required to phosphorylate the ProP-PD library were tested
in a phosphorylation assay.
1 Immobilize 1 lg/well anti-phospho-Ser/Thr/Tyr antibody
(MA1-38450; Invitrogen) or 0.5% BSA in Kinase buffer (50 mM
HEPES (pH 7.5), 10 mM MgCl2, and 1 mM EGTA) at a final
volume of 100 ll in a 96-well MaxiSorp microtiter plate (NUNC)
overnight at 4°C. Dilute 10 ll of phage library per trial in PBS
and precipitate it by adding one-fifth the final volume of PEG/
NaCl, incubate on ice for 10 min, and pellet the phage by
centrifugation at 12,000 g for 20 min.
2 Resuspend the phage pellet in Kinase buffer and add ATP
(100 lM final concentration) and kinase (200 or 400 ng/ml,
final concentration) to the phage solution. As a negative control,
perform identical reactions without addition of kinase alongside
the phosphorylation reactions.
3 Incubate the reactions in room temperature and stop the reac-
tions after 1 or 2 h by heat inactivation of the kinase for 10 min
at 60°C.
4 Remove the liquid from the microtiter plate and block the wells by
adding 200 ll kinase buffer with 0.5% BSA. Incubate for 2 h at
4°C.
5 Wash the wells with the immobilized antibody or BSA four
times with KT buffer (Kinase buffer + 0.05% Tween-20).
6 Add the phosphorylated library or the negative control (the
unphosphorylated library) to the wells with immobilized anti-
body and to the wells with immobilized BSA. Incubate for 2 h
at 4°C.
7 Wash the plates four times with KT buffer.
8 To detect bound phage, add 100 ll anti-M13 antibody (GE
Healthcare) diluted 1:5,000 in Kinase buffer supplemented with
0.05% Tween-20 and 0.5% BSA and incubate for 1 h at 4°C.
9 Wash the plate four times with KT buffer and one time with
Kinase buffer.
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10 Add 100 ll of TMB substrate per well, and allow the reaction to
develop for 5 min and then stop it by adding 100 ll 0.6 M H2SO4.
11 Detect the absorbance at 450 nM using a SpectraMax Plus
(Molecular Devices) plate reader.
Phage display selections
Phage selections were carried out for four rounds following a proto-
col by Huang and Sidhu (Huang & Sidhu, 2011) with minor modifi-
cations. Non-specific binding phage was removed by pre-selections
against immobilized GST throughout the selection. The selections
against the (pre-)phosphorylated wild-type library were performed
in 50 mM HEPES (pH 7.4) and 150 mM NaCl (HBS) following the
same procedure after pre-phosphorylation of the library.
1 Immobilize proteins (15 lg in 100 ll PBS) in a 96-well Maxi-
Sorp microtiter plate (NUNC) overnight at 4°C.
2 Start a 2YT culture of E. coli Omnimax supplemented with
100 lg/ml tetracycline to retain the F pilus epitope.
3 Block the wells with 200 ll 0.5% BSA in PBS for 2 h at 4°C.
4 Precipitate naı¨ve phage library (1011 cfu per selection) or ampli-
fied phage pool from the previous round of selection by adding
one-fifth the volume of PEG/NaCl.
5 Incubate on ice for 10 min, and pellet precipitated phage by
centrifugation at 5,300 g for 15 min. Resuspend the phage pellet
in 100 ll PBS per selection.
6 Add 100 ll of phage solution to the GST-coated pre-selection
wells and incubate for 1 h.
7 Transfer the phage solution to the immobilized target proteins
and allow it to bind for 2 h at 8°C.
8 Wash the plate four times with 200 ll cold wash buffer (PBS,
0.05% Tween-20).
9 Elute bound phage by incubation with 100 ll log phase (0.6–0.8
OD600) E. coli Omnimax for 30 min at 37°C with shaking (200
RPM).
10 Add 1012 cfu/ml M13K07 helper phage for hyperinfection of the
bacteria and incubate as above for 45 min.
11 Transfer the bacterial culture to 10 ml 2YT supplemented with
50 lg/ml carbenicillin, 25 lg/ml kanamycin, and 300 lM IPTG
and incubate overnight at 37°C while shaking.
12 Perform phage pool ELISA to monitor the progress of the selec-
tion as described previously (Huang & Sidhu, 2011).
Pre-phosphorylation of phage library
1 Precipitate the naive wild-type phage library (as described
above, 1.8 × 1010 cfu phage per selection).
2 Resuspend the precipitated phage pellets in 100 ll Kinase
buffer per selection and add ATP (100 lM final concentration)
and RPS6KA1 (500 ng/ml) to the phage solution. In parallel,
prepare a negative control where only ATP is added to the
phage pool.
3 Incubate the phosphorylation reaction for 2 h at room tempera-
ture. Stop the reaction through PEG/NaCl precipitation (as
described above).
4 Resuspend the phage pool in 100 ll HBS.
During the 4 days of pre-phosphorylation ProP-PD selections, the
input phage library of each day of selection was subjected to phos-
phorylation prior to phage selection.
Next-generation sequencing and analysis of phage selection
The naı¨ve library and the enriched phage pools of the third day of
selection were amplified and barcoded by PCR and analyzed by
NGS as described elsewhere (McLaughlin & Sidhu, 2013; Ivarsson
et al, 2014). The reads were demultiplexed using the barcode
sequences and filtered by discarding sequences with a Phred quality
score under 30. Sequences were mapped to the original library using
Bowtie (Langmead et al, 2009) with two mismatches between reads
and library sequence. Nucleotide mutations leading to amino acid
substitutions were subsequently removed. Cutoff values of NGS
counts were assigned for each pool. PWMs were generated based on
the remaining peptides (aligned on the C-termini) using WebLogo
(Crooks et al, 2004).
A correlation (Pearson correlation as implemented in R) analysis
of the sequences obtained from the binding-enriched phage pools
with the sequencing counts of the initial library showed that there is
a higher probability that a peptide that is present in high count in the
naı¨ve library to be selected during the phage display at all and there-
fore a relationship between the representation of a peptide in the
library to the screens sensitivity (Fig EV1). However, there was no
significant correlation of the actual read counts (selection “strength”)
and the initial representation in the library, reflecting the strong selec-
tion during phage display (wt+mimetic: P-value: 0.49, q = 0.08,
mimetic only: P-value: 0.069, q = 0.2, wt only: P-value: 0.12,
q = 0.17). Consequently, the amount of reads for each binder after
phage display is not a function of the amount of input reads in the
naı¨ve library and no modeling based on the input library frequencies
to score the interactions is necessary. To allow for comparison
between replicate selections, we used the fraction of NGS reads
within a certain set, instead of the absolute number of NGS reads, as
the absolute numbers differ between different NGS batches.
Cloning of constructs and mutagenesis
pDONR223-RPS6KA2 (Johannessen et al, 2010) was a gift from
William Hahn & David Root (Addgene plasmid # 23530). The gene
was PCR-amplified introducing HindIII and EcoRI restriction sites
along with the C-terminal phosphomimetic (S730E) or phosphoin-
hibiting (S730A) mutations, or the PDZbm deletion (T731-L733).
pKH3-human RSK1 was a gift from John Blenis (Addgene plasmid #
13841; Richards et al, 2001). The gene was PCR-amplified introduc-
ing HindIII and EcoRI restriction sites, and a and PDZbm deletion
(T733-L735) was generated. The genes (wild type and mutants)
were cloned into 3xFlag CMV-10 vector and subjected to Sanger
sequencing. Site-directed mutagenesis to introduce the single-point
mutations K746A, K762A, R762A, and R801A in Scribble PDZ1 in
pETM-11 was performed using the QuikChange protocol.
MST affinity measurements
Affinities for wild-type, phosphorylated, and phosphomimetic FITC-
labeled synthetic peptides (TANC-1: KR(S/pS/E)FIESNV; RPS6KA2:
RLT(S/PS/E)TRL; MCC: HTNET(S/PS/E)L) were obtained from
GeneCust, and the peptides were dissolved in 100% dimethyl
sulfoxide (DMSO) to a concentration of 1–5 mM. The peptides were
diluted in 50 mM Tris–HCl, pH 7.4, and 0.1% Tween-20 for affinity
measurements with Scribble PDZ1 and DLG PDZ2. For Shank1 PDZ,
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the peptides were diluted in PBS, 10 mM MgCl2, and 0.05% Tween-
20. The protein was subjected to a 1:1 dilution series in a 384-well
microtiter plate. Peptides were added to a final concentration in the
range of 25–50 nM. The samples were run in standard capillaries
with a blue filter on a Monolith NT.Automated MST (NanoTemper)
with MST power 20 or 40. The experiments were carried out in trip-
licate using the same batch of protein and peptides. Statistical
assessment was made by one-way ANOVA comparing the change in
affinity for the mimetic and phosphorylated peptide to the unphos-
phorylated peptide.
ITC experiments
Peptides and proteins were dialyzed in the same beaker in 20 mM
HEPES, pH 7.4. The experiments were carried out in 25°C in an
iTC200 (Malvern Instruments) with a protein concentration in the
cell of 50–100 lM and between 0.64 and 3 mM peptide in the
syringe. All experiments were done in triplicate with the same batch
of protein and peptides. The results were analyzed using Origin 7
(OriginLab Corporation). The peptide to protein stoichiometry was
fixed between replicates to 0.8–1.1 (depending on peptide) and the
baseline was corrected to get a low chi value in the curve fit, using
single-site binding. Statistical assessment of binding affinity between
unphosphorylated and phosphorylated peptides was done by
unpaired Student’s t-test comparing the mean  SD between the
triplicate titrations.
NMR experiments
NMR experiments were recorded on Bruker 600- and 900-MHz spec-
trometers, equipped with triple-resonance cryogenic temperature
probes at 298 K. The protein complexes were formed by titrating
unlabeled phosphopeptide (pRPS6KA2) until saturating amounts
with labeled Scribble PDZ1 domain (500 lM). Prior to the titration,
0.01% NaN3 and 5% D2O were added to the samples. For assign-
ment of the protein backbone, 2D [1H,15N]-HSQC, 3D HNCACB, and
[1H,1H]-NOESY-[1H,15N]-HSQC experiments (Cavanagh et al, 2007)
were performed. Side chains were assigned using the following 3D
experiments: [1H,15N]-HSQC-[1H13C-13C1H]-TOCSY (60 ms mixing
time), [1H,1H]-NOESY-[1H,13C]-HSQC, [1H,13C]-HSQC-[1H13C-13
C1H]-TOCSY (60 ms mixing time) in combination with 2D [1H,15N]-
HSQC, and 2D [1H,13C]-HSQC-CT(REFS). /-angle-restraining 3JHNHA
couplings were determined from a 3D HNHA-type experiment
using quantitative J-coupling intensity evolution (Vuister & Bax,
1994). Distance restraints were collected in the following NOESY
experiments, and the following parameters were used: 3D NOESY-
[1H,15N]-HMQC and NOESY-[1H,13C]-HMQC with 60 ms mixing
time and 128 (15N or 13C) × 200 (1H) × 2,048 (1H, direct) number
of points (Cavanagh et al, 2007). Standard 2D HSQC titration
experiments were made for phosphorylated and unphosphorylated
MCC and MAPK12 peptides as above.
Co-immunoprecipitations and GST-pulldowns
The plasmids encoding 3xFlag RPS6KA2 wild type and mutants
thereof, 3xFlag RPS6KA1 and mutants thereof, and GFP-tagged
full-length human Scribble (Navarro et al, 2005) were Midipreped
using PureLink HiPure Plasmid Midiprep Kit (Invitrogen). HEK293
cells were maintained in DMEM supplied with 10% fetal bovine
serum and 1× non-essential amino acids and 1% Pen/Strep (Gibco).
Prior to transfection, the cells were plated with a density of 5 × 105 in
3 ml complete growth medium for 24 h and then co-transfected with
a 160 ll 1:3 mixture of plasmids encoding GFP-tagged Scribble and
Flag-tagged RPS6KA2 constructs of (3.3 lg DNA diluted in 155 ll
Opti-MEM (Gibco) and 9.9 ll FuGENE HD (Promega)). For GST-
pulldown, HEK293 cells were transfected with the 3xFlag CMV-10
RPS6KA2 plasmid or the mutant variants thereof or 3xFlag RPS6KA1
or mutants thereof. After 48 h, the cells were lysed with 1 ml lysis
buffer (50 mM Tris–HCl, pH 7.4, 150 mM NaCl, 10 mM Na3VO4,
10 mM sodium pyrophosphate, 10 mM NaF, 1× cOmplete Mini
EDTA-free protease inhibitor), supplemented with 0.5% Nonidet
P-40, for 30 min at 4°C. 500 ll of the cell lysate was immunoprecipi-
tated with anti-Flag M2 magnetic beads (Sigma-Aldrich) overnight at
4°C. One milliliter of the GST-pulldown lysates were incubated with
50 lg GST-Scribble PDZ1 for 1 h at 4°C and precipitated using GSH-
magnetic beads (Sigma-Aldrich) overnight at 4°C. The beads were
washed three times with 1 ml ice-cold lysis buffer followed by the
addition of 50 ll SDS sample buffer (Bio-Rad) and incubation at 95°C
for 10 min. The whole-cell lysate and the immunoprecipitate were
separated on precast SDS–PAGE gels (Mini-PROTEAN TGX; Bio-Rad)
and transferred to nitrocellulose membranes (Bio-Rad) for 16 h at
60 mA. The membranes were immunoblotted with anti-Flag (ab1162;
Abcam), anti-GFP (ab6556; Abcam), and anti-actin (ab1801; Abcam)
primary antibodies followed by HRP-conjugated anti rabbit secondary
antibody (Life technologies) and detected with Amersham ECL
Western Blotting Detection Reagent (GE Healthcare), and exposed to
high-performance chemiluminescence film (Amersham Hyperfilm
ECL; GE Healthcare) for 30–180 s and developed and fixed using
GBX developer and fixer (Carestream Dental).
Enrichment of predicted kinase phosphorylation sites
In order to assess kinase preferences for targets of the individual PDZ
domains, as well as for Scribble and DLG1 targets as a whole, we
employed NetworKIN (Linding et al, 2007) available in the KinomeX-
plorer online resource (Horn et al, 2014). To facilitate the prediction,
we mapped the C-terminal sequences to the proteins in the String
protein database (version 7.1 as used by NetworKIN) and removed
instances for which no unique mapping was possible. We retrieved a
maximum of 10 kinase substrate predictions per entry, using the stan-
dard parameters in the high-throughput workflow of the KinomeX-
plorer (minimum score 2 and maximum difference 4). We compared
the frequency of kinase predictions between the background set (all
mapped instances in the designed library) against predictions for indi-
vidual binders of each PDZ domain and for all PDZ domains of Scrib-
ble or DLG1, respectively. Significance has been assessed using
Fisher’s exact test (one-sided), and P-values have been adjusted for
multiple testing using the Bonferroni–Holmes correction.
Overlap with literature and functional enrichments
The previously reported Scribble and DLG1 ligands were retrieved
from Human Integrated Protein-Protein Interaction rEference
(HIPPIE) on May 17, 2018 (Alanis-Lobato et al, 2017). Venn
diagrams between known ligands and ligands found using phospho-
mimetic ProP-PD were made (http://bioinformatics.psb.ugent.be/
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webtools/Venn/). The overlaps with our previously reported ProP-
PD (Ivarsson et al, 2014) results were curated manually.
We used the two-set (set and background) comparison function
of GOrilla (Eden et al, 2009) to compute functional enrichments of
the selected binders versus the library sequences (with P-value
cutoff 103). We found it necessary to use the actual library design
as background, since a comparison of the library design to the
complete human proteome revealed that the library itself is biased
toward certain GO categories (see Table EV7). In concordance with
the kinase enrichment analysis, we mapped the peptides to Ensembl
identifiers and kept entries with unique mapping for the analysis.
Network analysis
We created a network representation of the detected binders using
Cytoscape (Shannon et al, 2003). In order to present the binders in
a functional network context, we used the STRING database (Szklar-
czyk et al, 2015) and selected additional proteins which have a
high-confidence (STRING score ≥ 0.8) connection to any of our bait
or binder proteins. We further filtered for proteins within KEGG
pathways selected from a STRING-based enrichment analysis (using
the STRING web-page analysis section). The final network is
presented in Fig 4C.
Data availability
The data sets and computer code produced in this study are avail-
able in the following databases:
• Protein–protein interactions: The International Molecular Exchange
Consortium IM-26482 (https://www.ebi.ac.uk/intact/query/IM-
26482)
• NMR structure of Scribble PDZ1: Protein Data Bank (PDB) 6ESP
(https://www.rcsb.org/structure/6ESP)
Expanded View for this article is available online.
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